...
首页> 外文期刊>Journal of Cancer Research and Therapeutics >Cost–utility analysis of screening for colorectal precancerous lesions and cancer in Beijing: A case–control study
【24h】

Cost–utility analysis of screening for colorectal precancerous lesions and cancer in Beijing: A case–control study

机译:北京市大肠癌前病变和癌症筛查的成本-效用分析:病例对照研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective: To provide an objective cost–utility evaluation of a colorectal cancer screening program in a hypothetical general population. Materials and Methods: A cost–utility analysis was conducted comparing screened individuals with the general population. Patients were evaluated as part of the screening program which conducted colorectal cancer risk assessments and performed colonoscopies from October 2012 to May 2013. Data were compared to a hypothetical group of the same size, consisting of the general population in which no cancer screening had been conducted. The cost and utility data have been published previously. Results: The average cost per quality-adjusted life year (QALY) of colorectal cancer screening population was 84,092 CNY, while the average cost per QALY of the general population was 122,530 CNY. The colorectal cancer screening program saved 43,530 CNY per additional QALY. Conclusion: The colorectal cancer screening program could improve health-related quality of life and reduce medical expenditure.
机译:目的:对假设的普通人群中的结直肠癌筛查计划进行客观的成本-效用评估。材料和方法:进行了成本-效用分析,比较了筛查的个体与普通人群。在2012年10月至2013年5月期间,作为筛查计划的一部分,对患者进行了评估,该计划进行了大肠癌风险评估并进行了结肠镜检查。将数据与相同规模的假设人群进行比较,该人群包括未进行癌症筛查的一般人群。成本和公用事业数据已在之前发布。结果:结直肠癌筛查人群的每质量调整生命年(QALY)的平均成本为84,092元,而普通人群的每QALY的平均成本为122,530元。大肠癌筛查程序每增加一个QALY即可节省43,530元人民币。结论:大肠癌筛查程序可以改善与健康有关的生活质量,并减少医疗费用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号